CTOs on the Move

MegaMex Foods

www.megamexfoods.com

 
MegaMex Foods, LLC. engages in marketing, selling, and supplying Mexican food products and ingredients in the United States.
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Provision Partners Cooperative

Provision Partners | Growing Together | farming, feed, agronomy, country store, cenex, petroleum, lp gas, gasoline, grain

Laird Superfood

Laird Superfood is an "Alternative Energy" company. Through its award-winning line of Coffee Creamers, Laird Superfood is focused on providing consumers with the strongest and most sustained all-natural energy source available in the marketplace today.

Urban Remedy

Urban Remedy is a plant-based, fresh organic food company that embodies the belief that Food is Healing.

PlantBaby

Clean-label, organic, plant-based foods and beverages to support families on the nutritional journey from infancy to adulthood.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.